As the Zika virus continues to spread, biopharmaceutical companies Inovio Pharmaceuticals, GlaxoSmithKline and Sanofi are attracting attention from Wall Street. The companies' stocks sky-rocketed during trading on Friday as they lead the race for developing a Zika vaccine.
Please to comment